Article Details

AstraZeneca to buy China-based Gracell Biotechnologies in $1.2 billion deal - AOL.com

Retrieved on: 2023-12-26 14:45:23

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca to buy China-based Gracell Biotechnologies in $1.2 billion deal - AOL.com. View article details on hiswai:

Excerpt

The cash deal aimed at bolstering AstraZeneca's portfolio values U.S.-listed Gracell at $2 per ordinary share or $10 per ADS of Gracell, ...

Article found on: www.aol.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up